RY 137.78 -0.2173% TD 79.12 0.4571% SHOP 98.5 0.0406% CNR 178.05 -0.7967% ENB 47.285 0.0953% CP 118.9 -1.3032% BMO 129.94 -0.5967% TRI 211.37 0.8637% CNQ 109.75 -2.5397% BN 54.31 1.3624% ATD 75.79 0.4506% CSU 3700.0 1.9287% BNS 67.02 -0.0298% CM 66.71 -0.67% SU 52.485 -2.3717% TRP 50.495 -0.6591% NGT 53.52 0.131% WCN 229.67 -0.2865% MFC 32.5 -1.4554% BCE 44.87 0.1116%

Avricore Health Inc

Healthcare CA AVCR

0.16CAD
0.03(23.08%)

Last update at 2024-04-11T15:27:00Z

Day Range

0.140.16
LowHigh

52 Week Range

0.130.37
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.81823M -1.70813M -1.17397M -1.91625M -4.13680M
Minority interest - - - - -
Net income -0.81823M -1.70813M -1.17397M -2.10561M -4.13680M
Selling general administrative 1.18M 1.72M 0.85M 1.38M 2.04M
Selling and marketing expenses - - - - -
Gross profit 0.46M 0.03M 0.02M 0.01M 0.04M
Reconciled depreciation 0.18M 0.02M 0.00000M 0.18M 0.54M
Ebit - -1.74574M -1.04891M -1.60315M -2.47402M
Ebitda -0.63518M -1.65171M -1.01501M -1.73064M -3.60119M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.81252M -1.73878M -0.85324M -1.59709M -2.88003M
Other operating expenses - - - - -
Interest expense 0.00000M 0.04M 0.16M 0.00514M 0.00010M
Tax provision - - - - -
Interest income 0.00809M 0.00058M 0.00000M 0.00040M 0.00171M
Net interest income 0.00266M -0.04466M -0.16486M -0.01065M -0.00236M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 1.77M 0.12M 0.03M 0.03M 0.23M
Total operating expenses 2.58M 1.86M 0.89M 1.63M 3.11M
Cost of revenue 1.31M 0.09M 0.02M 0.02M 0.19M
Total other income expense net -0.00837M 0.08M -0.15586M -0.30851M -1.25441M
Discontinued operations - - - -0.18936M -0.67866M
Net income from continuing ops -0.81823M -1.70813M -1.17397M -1.91625M -4.13680M
Net income applicable to common shares - -1.70813M -1.17397M -2.10561M -4.13680M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 2.57M 2.28M 0.44M 0.21M 1.20M
Intangible assets 0.03M 0.03M 0.00000M 0.00000M 0.43M
Earning assets - - - - -
Other current assets - 0.01M 0.06M 0.02M 0.02M
Total liab 0.60M 0.08M 1.15M 0.67M 0.31M
Total stockholder equity 1.96M 2.20M -0.71404M -0.46545M 0.89M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - 26.62M 22.29M 21.40M 20.78M
Capital stock 27.06M 26.62M 22.29M 21.40M 20.78M
Retained earnings -31.03434M -30.21612M -28.50799M -27.33402M -25.22841M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.62M 2.01M 0.30M 0.01M 0.08M
Cash and equivalents - - - - -
Total current liabilities 0.60M 0.08M 1.15M 0.67M 0.31M
Current deferred revenue - - - - -
Net debt - - 0.70M - -
Short term debt - - - - -
Short long term debt 0.04M 0.04M 1.00M - -
Short long term debt total - - - - -
Other stockholder equity - 5.79M 5.51M 5.47M 5.33M
Property plant equipment - 0.09M - - 0.02M
Total current assets 1.43M 2.16M 0.44M 0.21M 0.75M
Long term investments - - - - -
Net tangible assets - 2.17M -0.71404M -0.46545M 0.46M
Short term investments 0.01000M - - - -
Net receivables 0.75M 0.09M 0.01M 0.02M 0.28M
Long term debt - - - - -
Inventory - - - 0.00000M 0.10M
Accounts payable 0.26M 0.04M 0.13M 0.63M 0.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.00000M 0.45M
Deferred long term asset charges - - - - -
Non current assets total 1.14M 0.12M 0.00000M 0.00000M 0.45M
Capital lease obligations - - 0.00000M 0.02M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.20852M -0.14036M 0.00000M 0.00000M -0.15500M
Change to liabilities - -0.06959M -0.33904M 0.36M -0.05365M
Total cashflows from investing activities - -0.14036M -0.14036M -0.14036M -0.15500M
Net borrowings - -1.00000M 0.93M -0.05201M -0.05201M
Total cash from financing activities 0.25M 3.08M 1.51M 0.62M 1.40M
Change to operating activities - 0.07M 0.05M 0.11M 0.16M
Net income -0.81823M -1.70813M -1.17397M -2.10561M -4.13680M
Change in cash -1.39247M 1.71M 0.29M -0.07064M -0.47529M
Begin period cash flow 2.01M 0.30M 0.01M 0.08M 0.56M
End period cash flow 0.62M 2.01M 0.30M 0.01M 0.08M
Total cash from operating activities -0.43783M -1.23415M -1.22340M -0.68641M -1.72505M
Issuance of capital stock 0.00000M 2.40M 0.63M 0.64M 0.78M
Depreciation 0.18M 0.01M 0.01M 0.19M 0.54M
Other cashflows from investing activities - - - - -0.00500M
Dividends paid - - - - -
Change to inventory 0.00000M 0.00000M -0.18043M -0.18043M -0.18043M
Change to account receivables -0.68749M -0.07962M 0.00355M 0.00355M 0.00355M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.09860M -0.05524M 0.17M 0.00933M
Change to netincome - 0.53M 0.42M 0.76M 1.77M
Capital expenditures 1.20M 0.11M 0.11M 0.11M 0.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.14284M -0.07823M -0.47067M 0.47M 0.24M
Stock based compensation 0.33M 0.50M 0.13M 0.09M -
Other non cash items - 0.04M 0.14M 0.00514M 0.06M
Free cash flow -1.63635M -1.37452M -1.22340M -0.68641M -1.78005M

Fundamentals

  • Previous Close 0.13
  • Market Cap16.94M
  • Volume15000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.48087M
  • Revenue TTM3.11M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 0.03M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AVCR
Avricore Health Inc
0.03 23.08% 0.16 - - 5.45 9.38 5.33 -26.0936
TELO
Telo Genomics Corp
0.01 5.26% 0.20 - - - 5.76 -3.3322
JUMP
Leveljump Healthcare Corp
-0.005 6.25% 0.07 - - 0.79 1.52 1.42 19.92

Reports Covered

Stock Research & News

Profile

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Avricore Health Inc

789 West Pender Street, Vancouver, BC, Canada, V6C 1H2

Key Executives

Name Title Year Born
Mr. Hector Bremner CEO & Director 1982
Ms. Kiriaki Smith CPA, CFO, CGA, CPA CFO & Corp. Sec. 1967
Mr. Rodger Seccombe Head of Healthtab Division & Director 1981
Mr. Will Seccombe Communications Advisor NA
Dr. Allan Shapiro Mang. of Bus. Devel. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).